FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Healthcare Triangle, Inc. [ HCTI ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 11/09/2022 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 07/12/2021 | A | 750,000 | A | $0.001 | 750,000 | D | |||
Common Stock | 05/08/2020 | A | 25,500,000 | A | $0.3 | 25,500,000 | I | Note(1) | ||
Super Voting Preferred Stock | 07/12/2021 | A | 6,000 | A | $0.00 | 6,000 | D |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Incentive Stock Option (right to buy) | $0.4 | 12/31/2021 | 01/01/2026 | Common Stock | 150,000(2) | 150,000 | D | ||||||||
Incentive Stock Option (right to buy) | $0.4 | 07/12/2021 | 07/12/2026 | Common Stock | 250,000(3) | 250,000 | D | ||||||||
Stock Option (Right To Buy) | $0.19 | 11/09/2022 | 11/09/2027 | Common Stock | 250,000(4) | 350,000 | D |
Explanation of Responses: |
1. Consists of 25,500,000 shares of Common Stock owned directly by SecureKloud Technologies, Inc., a Nevada corporation ("SKT"), and thus owned indirectly by Mr. Venkatachari due to his voting control over HCTI Common Stock through his position as a director and the Chief Executive Officer and the beneficial owner of 37% of the voting securities of SKT, and his position as a director and the Chief Executive Officer of SecureKloud Technologies, Ltd., a publicly traded company in India, that is the 65.2% owner of SKT. |
2. Incentive stock option granted on January 1, 2021 of which 25% vested on December 31, 2021, the remaining balance of which vests monthly over 36 months. |
3. Granted pursuant to Mr. Venkatachari's employment agreement dated July 12, 2021 and filed as Exhibit 10.13 to Pre-Effective Amendment No. 4 to the Registration Statement on Form S-1 by Healthcare Triangle, Inc. (File No. 333-259180) on October 8, 2021. |
4. Incentive stock option granted 11/09/2022 under the Company's 2020 Plan. The options vested immediately, and are for a 5-year period. |
/s/ Suresh Venkatachari | 11/14/2022 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |